Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Summary

This is an open-label, prospective, multicentric, non-comparative, non-randomized Phase IV interventional study in which subjects pre-diagnosed with Growth Hormone Deficiency (GHD) were treated for 4 weeks with Saizen to compare the response between GHD children born appropriate for gestational age (AGA) and those born small for gestation age (SGA) after 4 weeks of Saizen therapy.

Timeline

Start

2007-03

Primary completion

2008-09

Completion

2009-04

Drugs

Indications